
Lurid Pharma Trading Private Limited
About Lurid Pharma Trading Private Limited
Data last updated:
Lurid Pharma Trading Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 30 November 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2012PTC245485. Its GSTIN is 10AACCL3961G1ZW (Bihar).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors including Rajeev Kumar and Rajni Kant Sinha.
Its last annual general meeting (AGM) was held on 29 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 4/123 P – Extn Mohan Garden, New Delhi, Delhi, India – 110059.
As per the financials filed for FY 2025, the company reported a revenue of ₹53.88 Lakh, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹92,480 (net margin 1.7%) and EBITDA of ₹1.26 Lakh (EBITDA margin 2.3%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 6% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Lurid Pharma Trading Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressE – 4/123 P – Extn Mohan Garden, New Delhi, Delhi, India – 110059
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Lurid Pharma Trading Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Lurid Pharma Trading is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Lurid Pharma Trading Private Limited, buy the company report.
Financials of Lurid Pharma Trading Private Limited
FY 2025 filings availableLurid Pharma Trading Private Limited reported revenue of ₹53.88 Lakh (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 9% growth in the latest year. EBITDA rose 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.26 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹92,480 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.3% | ||||
| Net Profit Margin | 1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lurid Pharma Trading Private Limited, buy the company report.
Board of directors of Lurid Pharma Trading Private Limited
Lurid Pharma Trading has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajeev Kumar | Director | 25 Apr 2013 | 13 Years 6 Months | Current |
| Rajni Kant Sinha | Director | 05 Apr 2013 | 13 Years 6 Months | Current |
| Rakesh Kumar | Director | 07 May 2019 | 7 Years 5 Months | Current |
Peer comparison
Lurid Pharma Trading Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jugaadoo Boy Private Limited | ₹53.93 Lakh (FY 2025) | -15.0% | Delhi, India | |||
| Vantage Kart Online Services Private Limited | ₹53.91 Lakh (FY 2025) | -27.0% | Ahmedabad, Gujarat, India | |||
| Alpha Ranch Private Limited | ₹53.91 Lakh (FY 2024) | -13.0% | Palladam, Tamil Nadu, India | |||
| Liberty Vinimay Private Limited | ₹53.91 Lakh (FY 2018) | -13.0% | Kolkata, West Bengal, India | |||
| Autrigaa Private Limited | ₹53.88 Lakh (FY 2024) | 242.0% | Delhi, India | |||
| Lurid Pharma Trading Private Limitedthis company | ₹53.88 Lakh (FY 2025) | ₹92,480 | 1.7% | 9.0% | New Delhi, Delhi, India | |
| Maruti Laminates Private Limited | ₹53.88 Lakh (FY 2024) | -11.0% | Ahmedabad, Gujarat, India | |||
| Mermaid Shipping Limited | ₹53.87 Lakh (FY 2025) | -30.0% | Thane, Maharashtra, India | |||
| Navam Capital Private Limited | ₹53.86 Lakh (FY 2025) | -2.0% | Kolkata, West Bengal, India | |||
| Akc Motors Private Limited | ₹53.86 Lakh (FY 2025) | -94.0% | Ludhiana, Punjab, India | |||
| Renotouch India Private Limited | ₹53.85 Lakh (FY 2024) | 1101216.0% | Delhi, India |
To see the full peer comparison of Lurid Pharma Trading Private Limited, buy the company report.
Auditor
Lurid Pharma Trading Private Limited is audited by RAKCHAMPS&CO LLP for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAKCHAMPS&CO LLP | FY 2017 | 131094W |
Shareholding
The shareholding of Lurid Pharma Trading Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Lurid Pharma Trading Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lurid Pharma Trading Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lurid Pharma Trading Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lurid Pharma Trading has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AACCL3961G1ZW | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Lurid Pharma Trading Private Limited, buy the company report.
Recent activity
Lurid Pharma Trading Private Limited has 9 board changes on record since 2013: 3 appointments and 6 cessations. The latest: Rakesh Kumar was appointed as Director on 07 May 2019.
Frequently asked questions
Lurid Pharma Trading is an active private limited company based in New Delhi, Delhi, India. The company works in chemical products, within the chemicals industry. It was incorporated on 30 November 2012 (14+ years old) and is registered under CIN U24233DL2012PTC245485.
Lurid Pharma Trading has 3 current directors:
- Rajeev Kumar - Director
- Rajni Kant Sinha - Director
- Rakesh Kumar - Director
The latest financial statements of Lurid Pharma Trading on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 August 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Lurid Pharma Trading is 10AACCL3961G1ZW, registered in Bihar.
The CIN (Corporate Identification Number) of Lurid Pharma Trading is U24233DL2012PTC245485. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lurid Pharma Trading was incorporated on 30 November 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Lurid Pharma Trading by revenue are Jugaadoo Boy Private Limited, Vantage Kart Online Services Private Limited, Alpha Ranch Private Limited, Liberty Vinimay Private Limited, Autrigaa Private Limited and 5 more, all in the same principal business activity (retail trading).
Rakesh Kumar was appointed as Director on 07 May 2019. Uday Chand Kungilwar ceased to be Additional Director on 02 Apr 2015. Rajeev Kumar ceased to be Additional Director on 30 Sep 2013. Lurid Pharma Trading has 9 board changes on record in total.
The registered office of Lurid Pharma Trading is at E – 4123 P – Extn Mohan Garden, New Delhi, Delhi, India – 110059.
Lurid Pharma Trading operates in the chemicals industry, in the chemical products segment.
The compliance status of Lurid Pharma Trading is compliant as of 26 July 2026. The company is actively filing with the Registrar of Companies.

